National Cancer Institute; Notice of Closed Meetings, 7357-7358 [2016-02707]

Download as PDF Federal Register / Vol. 81, No. 28 / Thursday, February 11, 2016 / Notices individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Integrative Nutrition and Metabolic Processes. Date: February 11, 2016. Time: 1:00 p.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda (Formerly Holiday Inn Select), 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review Officer, EMNR IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6182 MSC 7892, Bethesda, MD 20892, 301 435– 2514, riverase@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: February 4, 2016. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–02710 Filed 2–10–16; 8:45 am] BILLING CODE 4140–01–P Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Bo Hong, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD 20892, 301–996–6208, hongb@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Cancer Biology. Date: February 18, 2016. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Charles Morrow, MD, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6202, MSC 7804, Bethesda, MD 20892, 301–451– 4467, morrowcs@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: February 5, 2016. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2016–02705 Filed 2–10–16; 8:45 am] National Institutes of Health BILLING CODE 4140–01–P mstockstill on DSK4VPTVN1PROD with NOTICES Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Oncology 2— Translational Clinical Integrated Review Group; Radiation Therapeutics and Biology Study Section. Date: February 15–16, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. VerDate Sep<11>2014 16:52 Feb 10, 2016 Jkt 238001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 7357 Name of Committee: National Cancer Institute Special Emphasis Panel; Identification, Capture and Visualization, Methods in Tissue Sections. Date: March 17, 2016. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W246, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Nicholas J. Kenney, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W246 Rockville, MD 20850, 240–276–6374, nicholas.kenney@nih.gov Name of Committee: National Cancer Institute Special Emphasis Panel; Methods Involved in the Integration of Metabolomics Data. Date: March 21, 2016. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 5W030, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Nicholas J. Kenney, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division Of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W246, Rockville, MD 20850, 240– 276–6374, nicholas.kenney@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Assay Validation for High Quality Markers for NCISupported Clinical Trials. Date: March 24, 2016. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 2W904, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH 9609 Medical Center Drive, 7W114, Bethesda, MD 20892–9750, 240–276–6371, decluej@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Disease Penetrance of Cancer Susceptibility Gene. Date: April 7, 2016. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W032, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W242, Rockville, MD 20850, 240–276–6372, zouzhiq@mail.nih.gov. E:\FR\FM\11FEN1.SGM 11FEN1 7358 Federal Register / Vol. 81, No. 28 / Thursday, February 11, 2016 / Notices Name of Committee: National Cancer Institute Special Emphasis Panel; NCI R03 & R21 Omnibus SEP–15. Date: April 11, 2016. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Denise L. Stredrick, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W640, Rockville, MD 20850, 240–276–5053, stredrid@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: February 5, 2016. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–02707 Filed 2–10–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration mstockstill on DSK4VPTVN1PROD with NOTICES Advisory Committee for Women’s Services (ACWS); Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given of a meeting of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Advisory Committee for Women’s Services (ACWS) on February 24, 2016. The meeting will include discussions on The U.S. Preventive Services Task Force (USPSTF) Fifth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services for Women, including Intimate Partner Violence, Illicit Drug Use, Major Depressive Disorder, and Suicide Risk; the Federal Legislative process and women’s behavioral health; women and sexual abuse and coercion; certified community health clinics; and a conversation with the SAMHSA Acting Administrator. The meeting is open to the public and will be held at SAMHSA, 5600 Fishers Lane, Rockville, MD 20857, in Conference Room 5E49. Attendance by the public will be limited to space available. Interested persons may present data, information, or views, orally or in writing, on issues pending VerDate Sep<11>2014 16:52 Feb 10, 2016 Jkt 238001 before the committee. Written submissions should be forwarded to the contact person (below) on or before February 12, 2016. Oral presentations from the public will be scheduled at the conclusion of the meeting. Individuals interested in making oral presentations are encouraged to notify the contact person on or before February 12, 2016. Five minutes will be allotted for each presentation. The meeting may be accessed via telephone. To attend on site, obtain the call-in number and access code, submit written or brief oral comments, or request special accommodations for persons with disabilities, please register on-line at https://nac.samhsa.gov/ Registration/meetingsRegistration.aspx, or communicate with SAMHSA’s Designated Federal Officer, Ms. Nadine Benton (see contact information below). Substantive meeting information and a roster of Committee members may be obtained either by accessing the SAMHSA Committees’ Web site https:// www.samhsa.gov/about-us/advisorycouncils/advisory-committeewomen%E2%80%99s-services-awcs, or by contacting Ms. Benton. Committee Name: Substance Abuse and Mental Health Services Administration Advisory Committee for Women’s Services (ACWS). Date/Time/Type: Wednesday, February 24, 2016, from: 900 a.m. to 4:45p.m. EDT Open. Place: SAMHSA, 5600 Fishers Lane, Conference Room 5E49, Rockville, Maryland 20857. Contact: Nadine Benton, Designated Federal Official, SAMHSA’s Advisory Committee for Women’s Services, 5600 Fishers Lane, Rockville, Maryland 20857, Telephone: (240) 276–0127, Fax: (240) 276–2252, Email: nadine.benton@ samhsa.hhs.gov. Summer King, Statistician, SAMHSA. [FR Doc. 2016–02774 Filed 2–10–16; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given of the meeting of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) National Advisory Council (NAC) on February 26, 2016. The meeting will include a brief reflection on the February 25, 2016 Joint PO 00000 Frm 00075 Fmt 4703 Sfmt 9990 National Advisory Council meeting (JNAC) and presentations related to emerging issues and increasing engagement in quality care, followed by a Council discussion. The meeting is open to the public and will be held at the Bethesda North Marriott and Conference Center, 5701 Marinelli Road, Rockville, MD 20852. Attendance by the public will be limited to space available. Interested persons may present data, information, or views, orally or in writing, on issues pending before the Council. Written submissions should be forwarded to the contact person on or before February 16, 2016. Oral presentations from the public will be scheduled at the conclusion of the meeting. Individuals interested in making oral presentations are encouraged to notify the contact on or before February 16, 2016. Five minutes will be allotted for each presentation. The meeting may be accessed via telephone and web conferencing will be available. To attend on site; obtain the call-in number, access code, and/or web access link; submit written or brief oral comments; or request special accommodations for persons with disabilities, please register on-line at: https://nac.samhsa.gov/Registration/ meetingsRegistration.aspx, or communicate with SAMHSA’s Committee Management Officer, CDR Carlos Castillo (see contact information below). Substantive meeting information and a roster of Council members may be obtained either by accessing the SAMHSA Council’s Web site at https:// www.samhsa.gov/about-us/advisorycouncils/ or by contacting CDR Castillo. Substantive program information may be obtained after the meeting by accessing the SAMHSA Council’s Web site, https://nac.samhsa.gov/, or by contacting CDR Castillo. Council Name: Substance Abuse and Mental Health Services, Administration National Advisory Council. Date/Time/Type: February 26, 2016, 8:30 a.m. to 1:00 p.m. (EDT), Open. Place: Bethesda North Marriott and Conference Center, 5701 Marinelli Road, Rockville, Maryland 20852. Contact: CDR Carlos Castillo, Committee Management Officer and Designated Federal Official, SAMHSA National Advisory Council, 5600 Fishers Lane, Room 18E77A, Rockville, Maryland 20857 (mail), Telephone: (240) 276–2787, Email: carlos.castillo@ samhsa.hhs.gov. Summer King, Statistician, SAMHSA. [FR Doc. 2016–02775 Filed 2–10–16; 8:45 am] BILLING CODE 4162–20–P E:\FR\FM\11FEN1.SGM 11FEN1

Agencies

[Federal Register Volume 81, Number 28 (Thursday, February 11, 2016)]
[Notices]
[Pages 7357-7358]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-02707]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and contract proposals and 
the discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications and 
contract proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Identification, Capture and Visualization, Methods in Tissue 
Sections.
    Date: March 17, 2016.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W246, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Nicholas J. Kenney, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W246 Rockville, MD 20850, 240-276-6374, 
nicholas.kenney@nih.gov

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Methods Involved in the Integration of Metabolomics Data.
    Date: March 21, 2016.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 5W030, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Nicholas J. Kenney, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division Of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W246, Rockville, MD 20850, 240-276-6374, 
nicholas.kenney@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Assay Validation for High Quality Markers for NCI-Supported 
Clinical Trials.
    Date: March 24, 2016.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2W904, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH 9609 Medical 
Center Drive, 7W114, Bethesda, MD 20892-9750, 240-276-6371, 
decluej@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Disease Penetrance of Cancer Susceptibility Gene.
    Date: April 7, 2016.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W032, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W242, Rockville, MD 20850, 240-276-6372, zouzhiq@mail.nih.gov.


[[Page 7358]]


    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI R03 & R21 Omnibus SEP-15.
    Date: April 11, 2016.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Denise L. Stredrick, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W640, Rockville, MD 20850, 240-276-5053, stredrid@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 5, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-02707 Filed 2-10-16; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.